Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain

Molecular Psychiatry volume 21, pages 1077–1084 (2016)Cite this article

Subjects

Abstract

The dopamine (DA) and serotonin (5-HT) neurotransmission systems are of fundamental importance for normal brain function and serve as targets for treatment of major neuropsychiatric disorders. Despite central interest for these neurotransmission systems in psychiatry research, little is known about the regulation of receptor and transporter density levels. This lack of knowledge obscures interpretation of differences in protein availability reported in psychiatric patients. In this study, we used positron emission tomography (PET) in a twin design to estimate the relative contribution of genetic and environmental factors, respectively, on dopaminergic and serotonergic markers in the living human brain. Eleven monozygotic and 10 dizygotic healthy male twin pairs were examined with PET and [11C]raclopride binding to the D2- and D3-dopamine receptor and [11C]WAY100635 binding to the serotonin 5-HT1A receptor. Heritability, shared environmental effects and individual-specific non-shared effects were estimated for regional D2/3 and 5-HT1A receptor availability in projection areas. We found a major contribution of genetic factors (0.67) on individual variability in striatal D2/3 receptor binding and a major contribution of environmental factors (pairwise shared and unique individual; 0.70–0.75) on neocortical 5-HT1A receptor binding. Our findings indicate that individual variation in neuroreceptor availability in the adult brain is the end point of a nature–nurture interplay, and call for increased efforts to identify not only the genetic but also the environmental factors that influence neurotransmission in health and disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Sawaguchi T, Goldman-Rakic PS . D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 1991; 251: 947–950.

    Article  CAS  Google Scholar 

  2. Volkow ND, Gur RC, Wang GJ, Fowler JS, Moberg PJ, Ding YS et al. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry 1998; 155: 344–349.

    Article  CAS  Google Scholar 

  3. Bäckman L, Ginovart N, Dixon RA, Wahlin TB, Wahlin A, Halldin C et al. Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am J Psychiatry 2000; 157: 635–637.

    Article  Google Scholar 

  4. Mehta MA, Manes FF, Magnolfi G, Sahakian BJ, Robbins TW . Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers. Psychopharmacology (Berl) 2004; 176: 331–342.

    Article  CAS  Google Scholar 

  5. Lee B, Groman S, London ED, Jentsch JD . Dopamine D2/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys. Neuropsychopharmacology 2007; 32: 2125–2134.

    Article  CAS  Google Scholar 

  6. Reeves SJ, Mehta MA, Montgomery AJ, Amiras D, Egerton A, Howard RJ et al. Striatal dopamine (D2) receptor availability predicts socially desirable responding. Neuroimage 2007; 34: 1782–1789.

    Article  Google Scholar 

  7. Cervenka S, Gustavsson JP, Halldin C, Farde L . Association between striatal and extrastriatal dopamine D2-receptor binding and social desirability. Neuroimage 2010; 50: 323–328.

    Article  Google Scholar 

  8. Zald DH, Cowan RL, Riccardi P, Baldwin RM, Ansari MS, Li R et al. Midbrain dopamine receptor availability is inversely associated with novelty-seeking traits in humans. J Neurosci 2008; 28: 14372–14378.

    Article  CAS  Google Scholar 

  9. Gjedde A, Kumakura Y, Cumming P, Linnet J, Møller A . Inverted-U-shaped correlation between dopamine receptor availability in striatum and sensation seeking. Proc Natl Acad Sci USA 2010; 107: 3870–3875.

    Article  CAS  Google Scholar 

  10. Weiland BJ, Heitzeg MM, Zald D, Cummiford C, Love T, Zucker RA et al. Relationship between impulsivity, prefrontal anticipatory activation, and striatal dopamine release during rewarded task performance. Psychiatry Res 2014; 223: 244–252.

    Article  Google Scholar 

  11. Jacobs BL, Azmitia EC . Structure and function of the brain serotonin system. Physiol Rev 1992; 72: 165–229.

    Article  CAS  Google Scholar 

  12. Whitaker-Azmitia PM . Serotonin and brain development: role in human developmental diseases. Brain Res Bull 2001; 56: 479–485.

    Article  CAS  Google Scholar 

  13. Savitz J, Lucki I, Drevets WC . 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol 2009; 88: 17–31.

    Article  CAS  Google Scholar 

  14. Brunelin J, Fecteau S, Suaud-Chagny M-F . Abnormal striatal dopamine transmission in schizophrenia. Curr Med Chem 2013; 20: 397–404.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Howes OD, Kambeitz J, Kim E, Stahl D, Slifstein M, Abi-Dargham A et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry 2012; 69: 776–786.

    Article  CAS  Google Scholar 

  16. Kambeitz J, Abi-Dargham A, Kapur S, Howes OD . Alterations in cortical and extrastriatal subcortical dopamine function in schizophrenia: systematic review and meta-analysis of imaging studies. Br J Psychiatry 2014; 204: 420–429.

    Article  Google Scholar 

  17. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F . Imaging dopamine’s role in drug abuse and addiction. Neuropharmacology 2009; 56: 3–8.

    Article  CAS  Google Scholar 

  18. Volkow ND, Wang G-J, Fowler JS, Tomasi D, Telang F . Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci USA 2011; 108: 15037–15042.

    Article  CAS  Google Scholar 

  19. Narendran R, Martinez D, Mason NS, Lopresti BJ, Himes ML, Chen C-M et al. Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography study. Synapse 2011; 65: 1344–1349.

    Article  CAS  Google Scholar 

  20. Stokes PRA, Egerton A, Watson B, Reid A, Lappin J, Howes OD et al. History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability. J Psychopharmacol 2012; 26: 144–149.

    Article  CAS  Google Scholar 

  21. Volkow ND, Wang G-J, Telang F, Fowler JS, Alexoff D, Logan J et al. Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity. Proc Natl Acad Sci USA 2014; 111: E3149–E3156.

    Article  CAS  Google Scholar 

  22. Shrestha S, Hirvonen J, Hines CS, Henter ID, Svenningsson P, Pike VW et al. Serotonin-1A receptors in major depression quantified using PET: controversies, confounds, and recommendations. Neuroimage 2012; 59: 3243–3251.

    Article  CAS  Google Scholar 

  23. Neale M, Cardon L . Methodology for genetic studies of twins and families. Kluwer Academic Publishers: Dordrecht, Boston, MA, USA, 1992.

    Book  Google Scholar 

  24. Pinborg LH, Arfan H, Haugbol S, Kyvik KO, Hjelmborg JVB, Svarer C et al. The 5-HT2A receptor binding pattern in the human brain is strongly genetically determined. Neuroimage 2008; 40: 1175–1180.

    Article  Google Scholar 

  25. Stokes PR a, Shotbolt P, Mehta M a, Turkheimer E, Benecke A, Copeland C et al. Nature or nurture? Determining the heritability of human striatal dopamine function: an [18F]-DOPA PET study. Neuropsychopharmacology 2013; 38: 485–491.

    Article  CAS  Google Scholar 

  26. Lichtenstein P, De Faire U, Floderus B, Svartengren M, Svedberg P, Pedersen NL . The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. J Intern Med 2002; 252: 184–205.

    Article  CAS  Google Scholar 

  27. Spitzer RL, Williams JBW, Gibbon M . Structured Clinical Interview for DSM-III-R - Non Patient Version (SCID-NP). Biometrics Research Department, New York State Psychiatric Institute: : NY, USA, 1986.

    Google Scholar 

  28. Farde L, Hall H, Pauli S, Halldin C . Variability in D2-dopamine receptor density and affinity: a PET study with [11C]raclopride in man. Synapse 1995; 20: 200–208.

    Article  CAS  Google Scholar 

  29. Borg J, Henningsson S, Saijo T, Inoue M, Bah J, Westberg L et al. Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humans. Int J Neuropsychopharmacol 2009; 12: 783–792.

    Article  CAS  Google Scholar 

  30. Hirvonen J, van Erp TGM, Huttunen J, Aalto S, Någren K, Huttunen M et al. Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Arch Gen Psychiatry 2005; 62: 371–378.

    Article  CAS  Google Scholar 

  31. Hannelius U, Gherman L, Mäkelä V-V, Lindstedt A, Zucchelli M, Lagerberg C et al. Large-scale zygosity testing using single nucleotide polymorphisms. Twin Res Hum Genet 2007; 10: 604–625.

    Article  Google Scholar 

  32. Wienhard K, Dahlbom M, Eriksson L, Michel C, Bruckbauer T, Pietrzyk U et al. The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr 18: 110–118.

  33. Bergström M, Boëthius J, Eriksson L, Greitz T, Ribbe T, Widén L . Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J Comput Assist Tomogr 1981; 5: 136–141.

    Article  Google Scholar 

  34. Langer O, Någren K, Dolle F, Lundkvist C, Sandell J, Swahn C-G et al. Precursor synthesis and radiolabelling of the dopamine D2 receptor ligand [11C]raclopride from [11C]methyl triflate. J Label Compd Radiopharm 1999; 42: 1183–1193.

    Article  CAS  Google Scholar 

  35. Hall H, Lundkvist C, Halldin C, Farde L, Pike V, McCarron J et al. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635. Brain Res 1997; 745: 96–108.

    Article  CAS  Google Scholar 

  36. Schain M, Tóth M, Cselényi Z, Stenkrona P, Halldin C, Farde L et al. Quantification of serotonin transporter availability with [11C]MADAM—a comparison between the ECAT HRRT and HR systems. Neuroimage 2012; 60: 800–807.

    Article  CAS  Google Scholar 

  37. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR et al. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 2001; 21: 1034–1057.

    Article  CAS  Google Scholar 

  38. Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang D-R, Huang Y et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 2003; 23: 285–300.

    Article  CAS  Google Scholar 

  39. Roland PE, Zilles K . Brain atlases—a new research tool. Trends Neurosci 1994; 17: 458–467.

    Article  CAS  Google Scholar 

  40. Lammertsma AA, Hume SP . Simplified reference tissue model for PET receptor studies. Neuroimage 1996; 4: 153–158.

    Article  CAS  Google Scholar 

  41. Gunn RN, Sargent PA, Bench CJ, Rabiner EA, Osman S, Pike VW et al. Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. Neuroimage 1998; 8: 426–440.

    Article  CAS  Google Scholar 

  42. Cselényi Z, Olsson H, Halldin C, Gulyás B, Farde L . A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 and [11C]WAY 100635. Neuroimage 2006; 32: 1690–1708.

    Article  Google Scholar 

  43. Boker S, Neale M, Maes H, Wilde M, Spiegel M, Brick T et al. OpenMx: an open source extended structural equation modeling framework. Psychometrika 2011; 76: 306–317.

    Article  Google Scholar 

  44. Boker S, Neale M, Maes H, Wilde M, Spiegel M, Brick T et al. OpenMx 1.3 User Guide 2012; http://openmx.psyc.virginia.edu/docs/OpenMx/latest/OpenMxUserGuide.pdf (accessed on 8 August 2014).

  45. Team RC. R: A language and environment for statistical computing. R Found. Stat. Comput. 2013; http://www.r-project.org/.

  46. Rabiner E a, Messa C, Sargent PA, Husted-Kjaer K, Montgomery A, Lawrence AD et al. A database of [(11)C]WAY-100635 binding to 5-HT(1A) receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables. Neuroimage 2002; 15: 620–632.

    Article  Google Scholar 

  47. Sullivan PF, Kendler KS, Neale MC . Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003; 60: 1187–1192.

    Article  Google Scholar 

  48. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57: 1313–1323.

    Article  CAS  Google Scholar 

  49. Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009; 373: 234–239.

    Article  CAS  Google Scholar 

  50. Chang Z, Lichtenstein P, Asherson PJ, Larsson H . Developmental twin study of attention problems: high heritabilities throughout development. JAMA Psychiatry 2013; 70: 311–318.

    Article  Google Scholar 

  51. Kendler KS, Gatz M, Gardner CO, Pedersen NL . A Swedish national twin study of lifetime major depression. Am J Psychiatry 2006; 163: 109–114.

    Article  Google Scholar 

  52. Jönsson EG, Nöthen MM, Grünhage F, Farde L, Nakashima Y, Propping P et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 1999; 4: 290–296.

    Article  Google Scholar 

  53. Pohjalainen T, Rinne JO, Någren K, Lehikoinen P, Anttila K, Syvälahti EK et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 1998; 3: 256–260.

    Article  CAS  Google Scholar 

  54. Hirvonen MM, Lumme V, Hirvonen J, Pesonen U, Någren K, Vahlberg T et al. C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 630–636.

    Article  CAS  Google Scholar 

  55. Willeit M, Praschak-Rieder N . Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: A review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry. Neuroimage 2010; 53: 878–892.

    Article  CAS  Google Scholar 

  56. Rilke O, May T, Oehler J, Wolffgramm J . Influences of housing conditions and ethanol intake on binding characteristics of D2, 5-HT1A, and benzodiazepine receptors of rats. Pharmacol Biochem Behav 1995; 52: 23–28.

    Article  CAS  Google Scholar 

  57. King MV, Seeman P, Marsden CA, Fone KCF . Increased dopamine D2High receptors in rats reared in social isolation. Synapse 2009; 63: 476–483.

    Article  CAS  Google Scholar 

  58. Fitzgerald ML, Mackie K, Pickel VM . The impact of adolescent social isolation on dopamine D2 and cannabinoid CB1 receptors in the adult rat prefrontal cortex. Neuroscience 2013; 235: 40–50.

    Article  CAS  Google Scholar 

  59. Morgan D, Grant KA, Gage HD, Mach RH, Kaplan JR, Prioleau O et al. Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat Neurosci 2002; 5: 169–174.

    CAS  Google Scholar 

  60. Hirvonen J, van Erp TGM, Huttunen J, Aalto S, Någren K, Huttunen M et al. Brain dopamine d1 receptors in twins discordant for schizophrenia. Am J Psychiatry 2006; 163: 1747–1753.

    Article  Google Scholar 

  61. Ito H, Kodaka F, Takahashi H, Takano H, Arakawa R, Shimada H et al. Relation between presynaptic and postsynaptic dopaminergic functions measured by positron emission tomography: implication of dopaminergic tone. J Neurosci 2011; 31: 7886–7890.

    Article  CAS  Google Scholar 

  62. Howes O, Bose S, Turkheimer F, Valli I, Egerton A, Stahl D et al. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. Mol Psychiatry 2011; 16: 885–886.

    Article  CAS  Google Scholar 

  63. Shotbolt P, Stokes PR, Owens SF, Toulopoulou T, Picchioni MM, Bose SK et al. Striatal dopamine synthesis capacity in twins discordant for schizophrenia. Psychol Med 2011; 41: 2331–2338.

    Article  CAS  Google Scholar 

  64. Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA et al. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 2001; 49: 81–96.

    Article  CAS  Google Scholar 

  65. Schott BH, Minuzzi L, Krebs RM, Elmenhorst D, Lang M, Winz OH et al. Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. J Neurosci 2008; 28: 14311–14319.

    Article  CAS  Google Scholar 

  66. Tziortzi AC, Haber SN, Searle GE, Tsoumpas C, Long CJ, Shotbolt P et al. Connectivity-based functional analysis of dopamine release in the striatum using diffusion-weighted mri and positron emission tomography. Cereb Cortex 2013; 24: 1165–1177.

    Article  Google Scholar 

  67. Le Poul E, Boni C, Hanoun N, Laporte AM, Laaris N, Chauveau J et al. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 2000; 39: 110–122.

    Article  CAS  Google Scholar 

  68. Bravo JA, Dinan TG, Cryan JF . Early-life stress induces persistent alterations in 5-HT1A receptor and serotonin transporter mRNA expression in the adult rat brain. Front Mol Neurosci 2014; 7: 24.

    Article  Google Scholar 

  69. Choi JY, Shin S, Lee M, Jeon TJ, Seo Y, Kim CH et al. Acute physical stress induces the alteration of the serotonin 1A receptor density in the hippocampus. Synapse 2014; 68: 363–368.

    Article  CAS  Google Scholar 

  70. Murrough JW, Czermak C, Henry S, Nabulsi N, Gallezot J-D, Gueorguieva R et al. The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding. Arch Gen Psychiatry 2011; 68: 892–900.

    Article  Google Scholar 

  71. Sullivan GM, Ogden RT, Huang Y-Y, Oquendo MA, Mann JJ, Parsey R V . Higher in vivo serotonin-1a binding in posttraumatic stress disorder: a PET study with [11C]WAY-100635. Depress Anxiety 2013; 30: 197–206.

    Article  CAS  Google Scholar 

  72. Laruelle M . The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Brain Res Rev 2000; 31: 371–384.

    Article  CAS  Google Scholar 

  73. Paterson LM, Tyacke RJ, Nutt DJ, Knudsen GM . Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. J Cereb Blood Flow Metab 2010; 30: 1682–1706.

    Article  CAS  Google Scholar 

  74. Parsey RV, Arango V, Olvet DM, Oquendo MA, Van Heertum RL, John Mann J . Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography. J Cereb Blood Flow Metab 2005; 25: 785–793.

    Article  CAS  Google Scholar 

  75. Parsey RV, Ogden RT, Miller JM, Tin A, Hesselgrave N, Goldstein E et al. Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations. Biol Psychiatry 2010; 68: 170–178.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was funded by the Swedish Research Council (VR 09114 and 2009-7912). We thank the members of the PET group and the staff at the Swedish Twin Registry at the Karolinska Institutet, for assistance.

Author information

Authors and Affiliations

  1. Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden

    J Borg, S Cervenka, G J Matheson, E G Jönsson, T Ichimiya, P Stenkrona, C Halldin & L Farde

  2. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

    J Borg, R Kuja-Halkola, P Lichtenstein & H Larsson

  3. NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, Psychiatry Section, University of Oslo, Oslo, Norway

    E G Jönsson

  4. Danish Research Centre for Magnetic Resonance, Copenhagen University Hospital, Hvidovre, Denmark

    S Henningsson

  5. Department of Neuropsychiatry, Nippon Medical School, Tokyo, Japan

    T Ichimiya

  6. AstraZeneca Translational Science Center at Karolinska Institutet, Stockholm, Sweden

    L Farde

Authors
  1. J Borg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Cervenka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Kuja-Halkola
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G J Matheson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E G Jönsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P Lichtenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S Henningsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T Ichimiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. H Larsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. P Stenkrona
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. C Halldin
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. L Farde
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J Borg.

Ethics declarations

Competing interests

Dr JB has received compensation as a member of the scientific advisory board of Astra Zeneca. Dr SC has received grant support from Astra Zeneca as co-investigator, and has served as a one-off speaker for Roche and Otsuka pharmaceuticals. Dr LF is partially employed at the Astra Zeneca Translational Science Center at Karolinska Institutet. The remaining authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Molecular Psychiatry website

Supplementary information

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Borg, J., Cervenka, S., Kuja-Halkola, R. et al. Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain. Mol Psychiatry 21, 1077–1084 (2016). https://doi.org/10.1038/mp.2015.147

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2015.147

This article is cited by

Search

Advanced search

Quick links